SCHEMBL7608322

SCHEMBL7608322

O=C(O)CCC(SCCS)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 10/20 0.48
ANPEP P15144 3/20 0.44
ENPEP Q07075 3/20 0.44
TET2 Q6N021 3/20 0.40
KDM4A O75164 2/20 0.40
KDM4C Q9H3R0 2/20 0.40
KDM2A Q9Y2K7 2/20 0.40
TET3 O43151 1/20 0.40
CYP1A2 P05177 2/20 0.39
GRM8 O00222 1/20 0.39
GRM6 O15303 1/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GSR P00390 1/20 0.39
GRIK1 P39086 1/20 0.39
GRM5 P41594 1/20 0.39
GRIA1 P42261 1/20 0.39
GRIA2 P42262 1/20 0.39
GRIA3 P42263 1/20 0.39
SLC1A3 P43003 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11363135 0.79 HTT (0.38) FOLH1ENPEP
SCHEMBL7608626 0.73 FOLH1 (0.60) FOLH1TET2KDM4AKDM4CKDM2A
SCHEMBL4169490 0.71 GRM8 (0.57) FOLH1ANPEPENPEPTET2KDM4A
SCHEMBL30191691 0.70 TET2 (0.46) FOLH1ANPEPENPEPTET2KDM4A
SCHEMBL7615482 0.69 FOLH1 (0.47) FOLH1ANPEPENPEPTET2KDM4A
SCHEMBL7798008 0.68 CPB1 (0.56) FOLH1CYP1A2
SCHEMBL3517922 0.67
SCHEMBL7618177 0.67 FOLH1 (0.62) FOLH1GRM3
SCHEMBL10961881 0.67 FOLH1 (0.42) FOLH1ANPEPENPEPTET2KDM4A
Ammonia Solution, Strong SCHEMBL10961158 0.67 FOLH1 (0.42) FOLH1ANPEPENPEPTET2KDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458775-B1 N-ACETYLATED .ALPHA.-LINKED ACIDIC DIPEPTIDASE (NAALADASE) INHIBITORS ENZYME ACTIVITY, PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH INHIBITORS, AND METHODS OF THEIR USE TO INHIBIT NAALADASE ENZYME ACTIVITY, THEREBY EFFECTING NEURONAL GUILFORD PHARMACEUTICAL INC. 2002-10-01 US disclosed
US-6265609-B1 INHIBIT N-ACETYLATED .ALPHA.-LINKED ACIDIC DIPEPTIDASE (NAALADASE) ENZYME ACTIVITY; IN DRUGS TO TREAT GLUTAMATE ABNORMALITIES; COMPULSIVE DISORDERS AND PROSTATE DISEASES, TO EFFECT NEURONAL ACTIVITIES GUILFORD PHARMACEUTICALS INC. 2001-07-24 US disclosed